Article Details
Retrieved on: 2024-06-03 16:07:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Daratumumab is a monoclonal antibody immunotherapy treatment that targets CD38, a glycoprotein that is overexpressed on the surface of malignant MM ...
Article found on: www.pharmacytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here